End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
292.5 TWD | +2.45% | +4.28% | +7.54% |
Sales 2024 * | 18.86B 584M | Sales 2025 * | 20.95B 649M | Capitalization | 77.52B 2.4B |
---|---|---|---|---|---|
Net income 2024 * | 4.82B 149M | Net income 2025 * | 6.17B 191M | EV / Sales 2024 * | 4.48 x |
Net Debt 2024 * | 6.89B 213M | Net Debt 2025 * | 2.64B 81.94M | EV / Sales 2025 * | 3.83 x |
P/E ratio 2024 * |
15.8
x | P/E ratio 2025 * |
12.3
x | Employees | 1,099 |
Yield 2024 * |
1.83% | Yield 2025 * |
2.57% | Free-Float | 48.47% |
Latest transcript on Lotus Pharmaceutical Co., Ltd.
1 day | +2.45% | ||
1 week | +4.28% | ||
Current month | +2.99% | ||
1 month | -4.88% | ||
3 months | +0.34% | ||
6 months | +5.60% | ||
Current year | +7.54% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 14-09-28 | |
I ling Tian
DFI | Director of Finance/CFO | - | 16-10-31 |
Ying Ming Yue
COO | Chief Operating Officer | - | 22-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Vilhelm Wessman
CHM | Chairman | 54 | 15-04-22 |
Director/Board Member | 60 | 14-08-10 | |
Director/Board Member | 61 | 15-04-22 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 4 M€ | -4.41% | - | |
0.01% | 112 M€ | +5.18% | - | |
0.00% | 34 M€ | +4.32% | - | |
0.00% | 7 M€ | +0.11% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-05 | 292.5 | +2.45% | 5,241,340 |
24-06-04 | 285.5 | -1.21% | 2,141,408 |
24-06-03 | 289 | +1.76% | 3,458,079 |
24-05-31 | 284 | +2.90% | 6,004,666 |
24-05-30 | 276 | -1.78% | 4,030,262 |
End-of-day quote Taiwan S.E., June 04, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.54% | 2.34B | |
+42.69% | 750B | |
+34.11% | 606B | |
-6.87% | 356B | |
+18.74% | 326B | |
+6.76% | 286B | |
+18.08% | 246B | |
-3.44% | 213B | |
+11.35% | 213B | |
+2.64% | 167B |
- Stock Market
- Equities
- 1795 Stock